Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 60.0
(0.0%)
TWD 60.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.52 Million TWD | 0.0% |
| 2022 | - TWD | 0.0% |
| 2021 | - TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - TWD | -100.0% |
| 2024 Q2 | - TWD | 0.0% |
| 2023 Q1 | - TWD | 0.0% |
| 2023 FY | 9.52 Million TWD | 0.0% |
| 2023 Q4 | 4.76 Million TWD | 0.0% |
| 2023 Q3 | 4.76 Million TWD | 0.0% |
| 2023 Q2 | - TWD | 0.0% |
| 2022 FY | - TWD | 0.0% |
| 2022 Q4 | - TWD | 0.0% |
| 2022 Q3 | - TWD | 0.0% |
| 2021 FY | - TWD | 0.0% |
| 2020 FY | - TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.146% |
| Level Biotechnology Inc. | 660.61 Million TWD | 98.558% |
| Sagittarius Life Science Corp | 440.46 Million TWD | 97.838% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | 85.286% |
| TaiMed Biologics Inc. | 491.77 Million TWD | 98.063% |
| GlycoNex Incorporation | 2.54 Million TWD | -274.666% |
| VBI | 55.85 Million TWD | 82.948% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | 95.776% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 96.986% |
| Visgeneer Inc. | 147.99 Million TWD | 93.565% |
| Mycenax Biotech Inc. | 652.62 Million TWD | 98.541% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.436% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 94.751% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 97.556% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 58.122% |
| Enimmune corporation | 43.49 Million TWD | 78.103% |
| TaiRx, Inc. | 5.08 Million TWD | -87.407% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 1.02 Billion TWD | 99.069% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 96.402% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | 97.779% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 91.335% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | 94.726% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -688.411% |
| Lukas Biomedical Inc. | 231.83 Million TWD | 95.892% |
| RBC Bioscience Corporation | 172.46 Million TWD | 94.478% |
| BiOptic Inc. | 228.26 Million TWD | 95.828% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -10482.222% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -96.371% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.482% |
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -1208.242% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 52.842% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 97.596% |
| Neith Corporation | 39.9 Million TWD | 76.132% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 22.48 Million TWD | 57.635% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 93.254% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -1083.106% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 98.81% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 83.267% |
| AP Biosciences Inc | 32.25 Million TWD | 70.471% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.177% |
| 3D Global Biotech Inc. | 20.63 Million TWD | 53.841% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 96.972% |
| Intech Biopharm Corporation | 25.84 Million TWD | 63.152% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | 89.026% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 98.744% |
| TCI GENE Inc. | 333.85 Million TWD | 97.147% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -52811.111% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -852.4% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 88.857% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 94.053% |
| PharmaEngine, Inc. | 767.66 Million TWD | 98.759% |
| Savior Lifetec Corporation | 1.05 Billion TWD | 99.093% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 92.265% |
| OBI Pharma, Inc. | 41.54 Million TWD | 77.078% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | 95.936% |
| Acepodia, Inc. | 16.59 Million TWD | 42.602% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 75.537% |